Mutational studies with diquat and paraquat in vitro.
Diquat and paraquat were assayed in the following tests. (1) Ames test in Salmonella typhimurium (strains TA1535, TA1537, TA1538, TA98 and TA100) with and without rat-liver microsomal fractions. (2) Resistance to 8-azaguanine in Salmonella typhimurium (strain hisG46, TA92 and TA1535. (3) Repair test in Salmonella typhimurium (strains TA1538 and TA1978). (4) Gene mutations in Aspergillus nidulans: 8-AG resistance and methionine suppression (meth A1 locus). (5) Lethal recessive damage in Aspergillus nidulans. (6) Unscheduled DNA synthesis (UDS) in human epithelial-like cells (EUE). Diquat and paraquat were positive in S. typhimurium (in the repair test and the 8-AG resistance system), in A. nidulans (for gene mutations and lethal recessive damage induction) and in EUE cells (UDS induction).
D000818:Animals; D001233:Aspergillus nidulans / Q000187:drug effects*; D001375:Azaguanine; D002460:Cell Line; D004260:DNA Repair; D004178:Diquat / Q000378:metabolism / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D004848:Epithelium; D006801:Humans; D008862:Microsomes, Liver / Q000378:metabolism*; D009132:Muscles; D009154:Mutation / Q000187:drug effects*; D010269:Paraquat / Q000378:metabolism / Q000494:pharmacology*; D011726:Pyridinium Compounds / Q000494:pharmacology*; D051381:Rats; D012486:Salmonella typhimurium / Q000187:drug effects*; D012867:Skin
D011726:Pyridinium Compounds; D004178:Diquat; D010269:Paraquat; D001375:Azaguanine